Abstract
A gold-core, core-shell lipid nanoparticle design improved mRNA endosomal escape and boosted downstream expression and therapeutic performance versus conventional LNPs.
A nanoparticle platform study compared ionizable lipid-coated gold core-shell LNPs with conventional LNPs and found twofold higher endosomal escape, about 100-fold greater cytoplasmic mRNA diffusion, up to sevenfold higher in vivo protein production, stronger SARS-CoV-2 vaccine antibody responses, and better efficacy in a triple-negative breast cancer model.
This is platform and preclinical evidence spanning in vitro and animal models, so it does not yet establish safety or efficacy in humans.
Simplified